The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following ...
This came after the drug maker Abbott presented the justification for the Phase III clinical trial waiver along with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback